Korean J Pediatr Infect Dis. 2001 Nov;8(2):150-159. Korean.
Published online Nov 30, 2001.
Copyright © 2001 The Korean Society of Pediatric Infectious Diseases
Original Article

Persistency of Neutralizing Antibody to Inactivated Mouse Brain Derived Nakayama Japanese Encephalitis Vaccine and Current Observations of Booster Vaccination and Adverse Events

Young Mo Sohn, M.D., Ji Ho Park, M.D., Jin Soo Lee, M.D., Hye Ok Roh, M.D., Moran Ki, M.D.,* Bo Yul Choi, M.D., and Young Ho Kim
    • Department of Pediatrics, College of Medicine, Yonsei University, Seoul, Korea.
    • *Department of Preventive Medicine, College of Medicine, Eulji University, Daejon, Korea.
    • Department of Preventive Medicine, College of Medicine, Hanyang University, Seoul, Korea.
    • Mapo Public Health Center, Seoul, Korea.

Abstract

Purpose

We need to reconsider booster vaccination schedule of Japanese encephalitis vaccination. To do that we evaluate the long-term immunogenicity and the incidence of adverse events with inactivated mouse brain derived Nakayama Japanese encephalitis vaccine.

Methods

We tested neutalizing antibody for 311 elementary school students by plaque reduction neutralizing test(PRNT) at USAMC-AFRIMS(United States Armed Forces Research Institute of Medical Science/Department of Virology). We evaluated vaccine related adverse events by spontaneous reporting prospectively among 15,487 vaccinees who were vaccinated at public health center and 2,277 elementary school students who were immunized previously by a questionnaire and school health record.

Results

According to the time interval from the last booster injection of 311 children, PRNT antibody titers gradually decreased as the interval increased; 239 mIU/mL, 188 mIU/mL, 134 mIU/mL, 49 mIU/mL each at 6, 18, 30, 42 months after the last booster injection. The seropositivity rates were 98%, 99%, 95.6%, 71.4% each at 6, 18, 30, 42 months after the last booster injection. There were 21(0.13%) cases with systemic reactions among 15,487 vaccinees who had visited the hospital by prospective passive reporting system at public health center. According to the questionnaires and school health records in elementary school students, local induration and pain were 17.4% and 14.8%, respectively. Systemic reactions including fever, vomiting, rash were reported in few cases.

Conclusion

Biannual booster vaccination that has been recommended so far should not be necessary. Surveillance for adverse events with inactivated mouse brain derived Nakayama vaccine should be strengthened to better assess the number of cases and reactions associated with immunization.

Keywords
JEV; Vaccination; Neutralizing antibody; Persistency


Metrics
Share
PERMALINK